Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine. All OVP products are sold by third parties under third-party labels. It focuses on supporting veterinarians in canine and feline healthcare space. It offers a line of veterinary blood testing and other instruments. It manufactures biological and pharmaceutical products for other animal health companies.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Veterinary Medical Equipment & Supplies
- Sub-Industry: N/A
- Symbol: NASDAQ:HSKA
- CUSIP: N/A
- Web: www.heska.com
Capitalization:- Market Cap: $645.72 million
- Outstanding Shares: 7,226,000
Average Prices:- 50 Day Moving Avg: $98.08
- 200 Day Moving Avg: $98.84
- 52 Week Range: $46.51 - $115.00
P/E:- Trailing P/E Ratio: 45.55
- Foreward P/E Ratio: 41.18
- P/E Growth: 2.33
Sales & Book Value:- Annual Revenue: $137.69 million
- Price / Sales: 4.69
- Book Value: $13.42 per share
- Price / Book: 6.66
Profitability:- EBIDTA: $22.94 million
- Net Margins: 10.70%
- Return on Equity: 15.87%
- Return on Assets: 11.45%
Debt:- Current Ratio: 2.46%
- Quick Ratio: 1.12%
Misc:- Average Volume: 71,780 shs.
- Beta: 0.91
- Short Ratio: 3.99
Frequently Asked Questions for Heska Corporation (NASDAQ:HSKA)
What is Heska Corporation's stock symbol?
Heska Corporation trades on the NASDAQ under the ticker symbol "HSKA."
How were Heska Corporation's earnings last quarter?
Heska Corporation (NASDAQ:HSKA) released its quarterly earnings data on Thursday, August, 3rd. The company reported $0.44 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.37 by $0.07. The firm had revenue of $34.30 million for the quarter, compared to the consensus estimate of $33.35 million. Heska Corporation had a net margin of 10.70% and a return on equity of 15.87%. The company's quarterly revenue was up 14.3% on a year-over-year basis. During the same period last year, the firm earned $0.35 earnings per share. View Heska Corporation's Earnings History.
When will Heska Corporation make its next earnings announcement?
Where is Heska Corporation's stock going? Where will Heska Corporation's stock price be in 2017?
5 brokerages have issued 12-month price objectives for Heska Corporation's shares. Their predictions range from $71.00 to $129.50. On average, they anticipate Heska Corporation's share price to reach $104.25 in the next twelve months. View Analyst Ratings for Heska Corporation.
Who are some of Heska Corporation's key competitors?
Some companies that are related to Heska Corporation include OraSure Technologies (OSUR), Immunomedics (IMMU), Momenta Pharmaceuticals (MNTA), Accelerate Diagnostics (AXDX), Varex Imaging (VREX), Global Blood Therapeutics (GBT), Medpace Holdings (MEDP), LHC Group (LHCG), Aimmune Therapeutics (AIMT), Natus Medical Incorporated (BABY), Irhythm Tech (IRTC), Mazor Robotics (MZOR), Sangamo Therapeutics (SGMO), Dynavax Technologies Corporation (DVAX), Ascendis Pharma A/S (ASND), Esperion Therapeutics (ESPR), Glaukos Corporation (GKOS) and Acorda Therapeutics (ACOR).
Who are Heska Corporation's key executives?
Heska Corporation's management team includes the folowing people:
- Kevin S. Wilson, President, Chief Executive Officer
- John McMahon CPA, Chief Financial Officer, Vice President
- Michael J. McGinley Ph.D., President - Biologicals & Pharmaceuticals
- Jason A. Napolitano, Chief Operating Officer, Chief Strategist and Secretary
- Steven M Eyl, Executive Vice President - Global Sales and Marketing
- Steven M. Asakowicz, Executive Vice President - Companion Animal Health Sales
- Rodney A. Lippincott, Executive Vice President - Companion Animal Health Sales
- Nancy Wisnewski Ph.D., Executive Vice President - Diagnostic Operations and Product Development
- Sharon J. Larson, Lead Director
- William A. Aylesworth, Director
Who owns Heska Corporation stock?
Heska Corporation's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.53%), Neuberger Berman Group LLC (6.36%), Riverbridge Partners LLC (3.29%), Russell Investments Group Ltd. (3.17%), State Street Corp (2.71%) and Dimensional Fund Advisors LP (1.70%). Company insiders that own Heska Corporation stock include Carol Wrenn, G Irwin Gordon, Jason A Napolitano, John Mcmahon, Kevin S Wilson, Michael J Mcginley, Nancy Wisnewski, Rod Lippincott, Sharon J Larson, Sharon L Riley and Steve Asakowicz. View Institutional Ownership Trends for Heska Corporation.
Who sold Heska Corporation stock? Who is selling Heska Corporation stock?
Heska Corporation's stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Prudential Financial Inc., Cornerstone Capital Management Holdings LLC., Acadian Asset Management LLC, Wells Fargo & Company MN, Timpani Capital Management LLC, GSA Capital Partners LLP and Riverbridge Partners LLC. Company insiders that have sold Heska Corporation stock in the last year include Carol Wrenn, G Irwin Gordon, Jason A Napolitano, John Mcmahon, Kevin S Wilson, Michael J Mcginley, Nancy Wisnewski, Rod Lippincott and Steve Asakowicz. View Insider Buying and Selling for Heska Corporation.
Who bought Heska Corporation stock? Who is buying Heska Corporation stock?
Heska Corporation's stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Dimensional Fund Advisors LP, Geneva Advisors LLC, Fred Alger Management Inc., Marshall Wace North America L.P., Russell Investments Group Ltd., Fiera Capital Corp and QS Investors LLC. Company insiders that have bought Heska Corporation stock in the last two years include Sharon J Larson and Sharon L Riley. View Insider Buying and Selling for Heska Corporation.
How do I buy Heska Corporation stock?
Shares of Heska Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Heska Corporation's stock price today?
One share of Heska Corporation stock can currently be purchased for approximately $89.36.
MarketBeat Community Rating for Heska Corporation (NASDAQ HSKA)MarketBeat's community ratings are surveys of what our community members think about Heska Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Heska Corporation (NASDAQ:HSKA) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Hold Ratings, 2 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.40) |
| Consensus Price Target: | $104.25 (16.66% upside) |
Analysts' Ratings History for Heska Corporation (NASDAQ:HSKA)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/9/2017 | Benchmark Co. | Reiterated Rating | Buy | $106.00 -> $120.00 | High |  |
| 8/3/2017 | B. Riley | Reiterated Rating | Neutral | $96.50 | Medium | |
| 8/1/2017 | Aegis | Boost Price Target | Buy | $114.50 -> $129.50 | Low | |
| 1/26/2017 | CL King | Downgrade | Buy -> Neutral | | N/A | |
| 11/28/2016 | Sidoti | Downgrade | Buy -> Neutral | $71.00 | N/A | |
| 8/4/2016 | Gabelli | Downgrade | Buy -> Hold | | N/A | |
(Data available from 9/24/2015 forward)
Earnings History for Heska Corporation (NASDAQ:HSKA)Earnings History by Quarter for Heska Corporation (NASDAQ HSKA)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 11/7/2017 | | | | | | | | |
| 8/3/2017 | Q2 2017 | $0.37 | $0.44 | $33.35 million | $34.30 million | View | N/A | |
| 5/2/2017 | Q1 2017 | $0.24 | $0.61 | $33.31 million | $30.38 million | View | Listen | |
| 2/28/2017 | Q416 | $0.37 | $0.46 | $34.56 million | $39.50 million | View | Listen | |
| 11/1/2016 | Q316 | $0.26 | $0.45 | $31.36 million | $33.40 million | View | N/A | |
| 8/3/2016 | Q216 | $0.18 | $0.35 | $28.47 million | $30.00 million | View | N/A | |
| 5/3/2016 | Q116 | ($0.02) | $0.17 | $23.32 million | $27.10 million | View | N/A | |
| 3/3/2016 | Q415 | $0.17 | $0.28 | $28.31 million | $29.80 million | View | N/A | |
| 11/11/2015 | Q315 | $0.08 | $0.20 | $24.31 million | $28.00 million | View | Listen | |
| 7/29/2015 | Q215 | $0.10 | $0.17 | $24.11 million | $23.90 million | View | Listen | |
| 5/7/2015 | Q115 | $0.09 | $0.09 | $23.97 million | $22.90 million | View | N/A | |
| 3/5/2015 | Q414 | $0.15 | $0.12 | $24.20 million | $24.30 million | View | N/A | |
| 10/29/2014 | Q3 2014 | ($0.01) | $0.08 | $19.39 million | $21.81 million | View | N/A | |
| 7/30/2014 | Q2 | ($0.03) | $0.17 | $19.78 million | $22.92 million | View | N/A | |
| 5/8/2014 | Q1 2014 | ($0.01) | $0.03 | $20.31 million | $20.79 million | View | N/A | |
| 3/27/2014 | | $0.04 | $0.20 | | | View | N/A | |
| 8/7/2013 | Q2 2013 | ($0.01) | ($0.38) | $19.85 million | $18.30 million | View | N/A | |
| 11/13/2012 | Q312 | $0.08 | ($0.01) | $19.70 million | $16.90 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Heska Corporation (NASDAQ:HSKA)2017 EPS Consensus Estimate: $1.67
2018 EPS Consensus Estimate: $2.04
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.20 | $0.23 | $0.22 |
| Q2 2017 | 2 | $0.36 | $0.36 | $0.36 |
| Q3 2017 | 2 | $0.46 | $0.51 | $0.49 |
| Q4 2017 | 2 | $0.61 | $0.61 | $0.61 |
| Q1 2018 | 1 | $0.30 | $0.30 | $0.30 |
| Q2 2018 | 1 | $0.45 | $0.45 | $0.45 |
| Q3 2018 | 1 | $0.56 | $0.56 | $0.56 |
| Q4 2018 | 1 | $0.73 | $0.73 | $0.73 |
(Data provided by Zacks Investment Research)
Dividend History for Heska Corporation (NASDAQ:HSKA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Heska Corporation (NASDAQ:HSKA)Insider Ownership Percentage: 14.70%
Institutional Ownership Percentage: 81.36%
Insider Trades by Quarter for Heska Corporation (NASDAQ:HSKA)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/31/2017 | Nancy Wisnewski | EVP | Sell | 825 | $102.21 | $84,323.25 | |
| 8/30/2017 | John Mcmahon | CFO | Sell | 2,608 | $101.17 | $263,851.36 | |
| 6/1/2017 | Steve Asakowicz | EVP | Sell | 382 | $100.08 | $38,230.56 | |
| 5/31/2017 | Michael J Mcginley | Insider | Sell | 11,189 | $98.53 | $1,102,452.17 | |
| 5/31/2017 | Rod Lippincott | EVP | Sell | 11,227 | $98.00 | $1,100,246.00 | |
| 5/24/2017 | Jason A. Napolitano | COO | Sell | 5,000 | $100.50 | $502,500.00 | |
| 5/24/2017 | Nancy Wisnewski | EVP | Sell | 250 | $100.17 | $25,042.50 | |
| 5/23/2017 | Carol Wrenn | Director | Sell | 1,630 | $96.95 | $158,028.50 | |
| 5/23/2017 | John Mcmahon | CFO | Sell | 587 | $97.00 | $56,939.00 | |
| 5/4/2017 | Sharon J Larson | Director | Buy | 1,000 | $90.00 | $90,000.00 | |
| 4/11/2017 | Jason A. Napolitano | COO | Sell | 1,100 | $102.98 | $113,278.00 | |
| 4/10/2017 | Jason A. Napolitano | COO | Sell | 3,900 | $102.94 | $401,466.00 | |
| 3/9/2017 | John Mcmahon | CFO | Sell | 708 | $97.42 | $68,973.36 | |
| 3/9/2017 | Rod Lippincott | EVP | Sell | 5,157 | $97.87 | $504,715.59 | |
| 3/6/2017 | Kevin S Wilson | CEO | Sell | 8,000 | $90.00 | $720,000.00 | |
| 1/10/2017 | Jason A. Napolitano | COO | Sell | 5,000 | $74.73 | $373,650.00 | |
| 11/29/2016 | G Irwin Gordon | Director | Sell | 3,000 | $66.11 | $198,330.00 | |
| 11/28/2016 | John Mcmahon | CFO | Sell | 1,999 | $65.64 | $131,214.36 | |
| 11/22/2016 | Rod Lippincott | EVP | Sell | 5,000 | $64.85 | $324,250.00 | |
| 9/1/2016 | Jason A. Napolitano | CFO | Sell | 5,000 | $52.53 | $262,650.00 | |
| 8/29/2016 | Kevin S Wilson | CEO | Sell | 20,000 | $51.80 | $1,036,000.00 | |
| 8/24/2016 | John Mcmahon | VP | Sell | 137 | $51.30 | $7,028.10 | |
| 8/9/2016 | Steve Asakowicz | EVP | Sell | 4,698 | $52.55 | $246,879.90 | |
| 8/3/2016 | Kevin S Wilson | CEO | Sell | 30,736 | $47.34 | $1,455,042.24 | |
| 7/29/2016 | Kevin S Wilson | CEO | Sell | 20 | $43.95 | $879.00 | |
| 7/20/2016 | Kevin S Wilson | CEO | Sell | 3,779 | $44.02 | $166,351.58 | |
| 7/18/2016 | Kevin S Wilson | CEO | Sell | 5,465 | $44.31 | $242,154.15 | |
| 7/8/2016 | Kevin S Wilson | CEO | Sell | 10,000 | $42.37 | $423,700.00 | |
| 7/7/2016 | Jason A. Napolitano | CFO | Sell | 20,000 | $41.00 | $820,000.00 | |
| 7/6/2016 | Kevin S Wilson | CEO | Sell | 5,960 | $40.27 | $240,009.20 | |
| 7/1/2016 | Kevin S Wilson | CEO | Sell | 14,040 | $38.94 | $546,717.60 | |
| 6/2/2016 | Kevin S Wilson | CEO | Sell | 20,000 | $36.74 | $734,800.00 | |
| 5/12/2016 | Kevin S Wilson | CEO | Sell | 5,000 | $38.50 | $192,500.00 | |
| 5/10/2016 | Kevin S Wilson | CEO | Sell | 15,000 | $36.75 | $551,250.00 | |
| 5/10/2016 | Michael J Mcginley | Insider | Sell | 5,998 | $36.50 | $218,927.00 | |
| 5/10/2016 | Sharon L Riley | Director | Sell | 5,000 | $36.87 | $184,350.00 | |
| 5/9/2016 | Kevin S Wilson | CEO | Sell | 11,000 | $35.61 | $391,710.00 | |
| 5/5/2016 | Sharon L Riley | Director | Sell | 15,000 | $35.66 | $534,900.00 | |
| 5/3/2016 | Jason A Napolitano | CFO | Sell | 5,000 | $35.75 | $178,750.00 | |
| 3/8/2016 | Sharon L Riley | Director | Buy | 1,000 | $32.49 | $32,490.00 | |
| 1/27/2016 | Jason A Napolitano | CFO | Sell | 15,000 | $37.00 | $555,000.00 | |
| 12/29/2015 | Jason A. Napolitano | CFO | Sell | 3,700 | $40.03 | $148,111.00 | |
| 12/3/2015 | Kevin S Wilson | CEO | Sell | 6,000 | $35.50 | $213,000.00 | |
| 11/25/2015 | Michael J. Mcginley | insider | Sell | 958 | $33.62 | $32,207.96 | |
| 11/24/2015 | Michael J. Mcginley | insider | Sell | 1,427 | $33.33 | $47,561.91 | |
| 9/11/2015 | Jason A Napolitano | CFO | Sell | 1,699 | $33.51 | $56,933.49 | |
| 8/31/2015 | Jason A. Napolitano | CFO | Sell | 4,998 | $33.59 | $167,882.82 | |
| 8/31/2015 | Robert B. Grieve | insider | Sell | 11,098 | $33.77 | $374,779.46 | |
| 8/27/2015 | Robert B. Grieve | insider | Sell | 3,604 | $33.79 | $121,779.16 | |
| 8/17/2015 | Kevin S Wilson | CEO | Sell | 2,498 | $34.90 | $87,180.20 | |
| 8/17/2015 | Robert B Grieve | Insider | Sell | 8,033 | $34.91 | $280,432.03 | |
| 8/14/2015 | Kevin S Wilson | CEO | Sell | 2,101 | $34.90 | $73,324.90 | |
| 8/14/2015 | Rod Lippincott | EVP | Sell | 3,898 | $34.19 | $133,272.62 | |
| 7/13/2015 | Robert B Grieve | Insider | Sell | 1,000 | $29.99 | $29,990.00 | |
| 6/8/2015 | Kevin S Wilson | CEO | Sell | 11,810 | $30.08 | $355,244.80 | |
| 6/3/2015 | Robert B Grieve | Insider | Sell | 17,000 | $31.36 | $533,120.00 | |
| 6/1/2015 | Jason A Napolitano | CFO | Sell | 7,536 | $32.26 | $243,111.36 | |
| 5/22/2015 | Steven M Eyl | EVP | Sell | 5,981 | $30.19 | $180,566.39 | |
| 4/24/2015 | Robert B Grieve | Insider | Sell | 6,000 | $29.67 | $178,020.00 | |
| 4/13/2015 | Robert B Grieve | Insider | Sell | 4,000 | $26.54 | $106,160.00 | |
| 3/9/2015 | Jason A Napolitano | CFO | Sell | 5,765 | $26.02 | $150,005.30 | |
| 3/9/2015 | Kevin S Wilson | CEO | Sell | 10,000 | $25.38 | $253,800.00 | |
| 3/9/2015 | Robert B Grieve | Insider | Sell | 2,000 | $25.26 | $50,520.00 | |
| 11/30/2014 | David E Sveen | Director | Buy | 21,428 | $14.00 | $299,992.00 | |
| 11/30/2014 | Kevin S Wilson | CEO | Sell | 28,928 | $14.00 | $404,992.00 | |
| 11/21/2014 | Robert B Grieve | Insider | Sell | 6,500 | $15.25 | $99,125.00 | |
| 11/3/2014 | William A Aylesworth | Director | Sell | 5,000 | $13.67 | $68,350.00 | |
| 8/4/2014 | Robert B Grieve | Director | Sell | 12,000 | $13.57 | $162,840.00 | |
| 5/14/2014 | William Aylesworth | Director | Sell | 4,200 | $10.89 | $45,738.00 | |
| 3/31/2014 | Carol Wrenn | Director | Buy | 1,000 | $10.50 | $10,500.00 | |
| 3/31/2014 | Robert Grieve | CEO | Sell | 7,000 | $10.50 | $73,500.00 | |
| 3/1/2013 | William A Aylesworth | Director | Buy | 2,000 | $8.34 | $16,680.00 | |
| 10/3/2012 | Master Fund L.P. Cmc | Major Shareholder | Sell | 11,002 | $9.54 | $104,959.08 | |
| 8/28/2012 | William A Aylesworth | Director | Buy | 2,000 | $7.95 | $15,900.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Heska Corporation (NASDAQ:HSKA)
Latest Headlines for Heska Corporation (NASDAQ:HSKA)
| Source: |
|
| Date | Headline |
|---|
 | HSKA Makes Notable Cross Below Critical Moving Average
www.thestreet.com - September 20 at 12:40 AM |
 | Zacks: Brokerages Expect Heska Corporation (HSKA) Will Post Quarterly Sales of $36.28 Million
www.americanbankingnews.com - September 19 at 5:20 AM |
 | TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion
finance.yahoo.com - September 18 at 7:08 PM |
| Analysts Anticipate Heska Corporation (HSKA) Will Announce Earnings of $0.38 Per Share
www.americanbankingnews.com - September 17 at 4:20 PM |
| Heska Corporation (HSKA) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - September 17 at 3:10 PM |
| $36.28 Million in Sales Expected for Heska Corporation (HSKA) This Quarter
www.americanbankingnews.com - September 1 at 9:54 AM |
| Insider Selling: Heska Corporation (HSKA) EVP Sells 825 Shares of Stock
www.americanbankingnews.com - August 31 at 7:44 PM |
| John Mcmahon Sells 2,608 Shares of Heska Corporation (HSKA) Stock
www.americanbankingnews.com - August 31 at 7:42 PM |
| Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR
finance.yahoo.com - August 28 at 7:13 PM |
| Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : August 24, 2017
finance.yahoo.com - August 25 at 6:46 AM |
| Heska to Present at CL King's 15th Annual Best Ideas Conference 2017 on September 14, 2017
finance.yahoo.com - August 24 at 7:38 AM |
| Heska Corporation (HSKA) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - August 23 at 5:18 PM |
| Heska Corp. – Value Analysis (NASDAQ:HSKA) : August 17, 2017
finance.yahoo.com - August 17 at 12:36 AM |
| $0.42 EPS Expected for Heska Corporation (NASDAQ:HSKA) This Quarter
www.americanbankingnews.com - August 11 at 9:04 PM |
| Heska Corporation (HSKA) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - August 4 at 9:56 PM |
| Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : August 4, 2017
finance.yahoo.com - August 4 at 7:52 PM |
| FY2017 Earnings Estimate for Heska Corporation Issued By Gabelli (HSKA)
www.americanbankingnews.com - August 4 at 11:08 AM |
| Heska Corporation (NASDAQ:HSKA) Price Target Raised to $129.50 at Aegis
www.americanbankingnews.com - August 1 at 10:20 AM |
| Edited Transcript of HSKA earnings conference call or presentation 31-Jul-17 3:00pm GMT
finance.yahoo.com - August 1 at 12:05 AM |
 | Heska's (HSKA) CEO Kevin Wilson on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - July 31 at 7:03 PM |
| Investor Network: HESKA CORP to Host Earnings Call
finance.yahoo.com - July 31 at 7:03 PM |
| Heska Reports Second Quarter Results
finance.yahoo.com - July 31 at 7:03 PM |
| Heska posts 2Q profit
finance.yahoo.com - July 31 at 7:03 PM |
| Heska Corporation (HSKA) Releases Earnings Results, Beats Expectations By $0.07 EPS
www.americanbankingnews.com - July 31 at 2:26 PM |
| Heska Corporation (NASDAQ:HSKA) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 29 at 3:34 PM |
| Heska Corporation (HSKA) Rating Reiterated by B. Riley
www.americanbankingnews.com - July 28 at 9:40 PM |
| Heska Adds Growth Capital with $30 Million Credit Agreement with JPMorgan Chase
finance.yahoo.com - July 27 at 8:12 PM |
| Heska Corporation (NASDAQ:HSKA) to Release Earnings on Monday
www.americanbankingnews.com - July 27 at 11:51 AM |
| $33.63 Million in Sales Expected for Heska Corporation (HSKA) This Quarter
www.americanbankingnews.com - July 26 at 11:39 AM |
| Brokerages Anticipate Heska Corporation (NASDAQ:HSKA) to Announce $0.37 Earnings Per Share
www.americanbankingnews.com - July 24 at 2:16 PM |
| Comparing Heska Corporation (NASDAQ:HSKA) & IDEXX Laboratories (IDXX)
www.americanbankingnews.com - July 22 at 12:12 AM |
| Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10
finance.yahoo.com - July 20 at 8:20 PM |
| Comparing IDEXX Laboratories (IDXX) and Heska Corporation (HSKA)
www.americanbankingnews.com - July 17 at 6:24 PM |
| Heska Corporation (HSKA) Lowered to "Hold" at BidaskClub
www.americanbankingnews.com - July 17 at 12:00 AM |
| Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017
finance.yahoo.com - July 11 at 11:12 PM |
| ETFs with exposure to Heska Corp. : July 11, 2017
finance.yahoo.com - July 11 at 11:12 PM |
| Heska Corporation (HSKA) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - July 4 at 1:08 PM |
| ETFs with exposure to Heska Corp. : June 30, 2017
finance.yahoo.com - June 30 at 7:46 PM |
| Heska Corporation (HSKA) Expected to Announce Quarterly Sales of $33.63 Million
www.americanbankingnews.com - June 30 at 1:58 PM |
| Heska Corporation (HSKA) Expected to Announce Earnings of $0.37 Per Share
www.americanbankingnews.com - June 28 at 10:10 AM |
| Contrasting IDEXX Laboratories (IDXX) and Heska Corporation (HSKA)
www.americanbankingnews.com - June 22 at 10:46 PM |
| Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : June 22, 2017
finance.yahoo.com - June 22 at 1:27 PM |
| ETFs with exposure to Heska Corp. : June 19, 2017
finance.yahoo.com - June 19 at 4:42 PM |
| Heska Corp. :HSKA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 6:34 PM |
 | Heska (HSKA) Appoints Scott Humphrey to Board
www.streetinsider.com - June 13 at 5:32 PM |
| Scott Humphrey Joins Heska's Board of Directors
finance.yahoo.com - June 13 at 5:32 PM |
| Heska Corp (HSKA) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - June 9 at 2:38 PM |
| Zacks: Brokerages Expect Heska Corp (HSKA) Will Announce Quarterly Sales of $33.63 Million
www.americanbankingnews.com - June 4 at 9:30 AM |
| Why Heska (HSKA) Could Be Positioned for a Surge
finance.yahoo.com - June 2 at 7:08 PM |
| Heska Corp to Post FY2020 Earnings of $2.80 Per Share, Gabelli Forecasts (HSKA)
www.americanbankingnews.com - June 2 at 11:44 AM |
Heska Corporation (HSKA) Chart for Sunday, September, 24, 2017
